Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Pharma

    Pharma

    Psoriasis patient source of business for major IL-17 agents
    30 September 2024

    Psoriasis patient source of business for major IL-17 agents

    Source of business for leading IL-17 agents in psoriasis varies significantly by brand. While the majority of Cosentyx patients are previously treated with a TNF inhibitor, a sizable portion of Taltz patients have tried another IL-17 agent before starting Taltz. This finding suggests a ...

    Implications of the Inflation Reduction Act for cancer medicine development
    30 September 2024

    Implications of the Inflation Reduction Act for cancer medicine development

    The Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program (MDPNP) directs the Secretary of Health and Human Services (HHS) to set a maximum price for certain drugs in Medicare. The MDPNP is expected to reduce the pharmaceutical company revenues in Medicare from a selecte...

    Dr Michael Chen Standing With eProtein Discovery Holding eProtein Discovery Cartridge
    16 October 2024

    Nuclera closes $75 million USD financing

    Series C round led by Elevage Medical Technologies. Funding will accelerate the commercialization of Nuclera’s eProtein Discovery platform, to optimize protein expression and purification workflows within research labs globally. ...

    Plaster
    15 October 2024

    Benefits of a Nitrosamine Selective Detector

    Nitrosamines, such as N-Nitrosodimethylamine (NDMA), are carcinogenic compounds that can form during the drug manufacturing process and storage under certain conditions. These contaminants pose significant health risks, and their presence in medications like Ranitidine has alr...

    Awards
    16 October 2024

    Guardtech Group bag third win in two months with West Suffolk Innovation of the Year Award

    Haverhill-based cleanroom construction specialists scoop Bury Free Press Awards win for Innovation with portable container business Cleancube Mobile Cleanrooms ...

    4 August 2026

    Coping with Grief

    Dream
    11 October 2024

    DREAM: Develop, Research, Engineer, Assemble and Manufacture with a Guardtech Cleanrooms modular

    The Guardtech Group’s more modest modular specialists are helping applications reach new levels with their affordable yet high-quality systems ...

    4 August 2026

    Milner Seminar - Focus on immuno-oncology

    Join us on 28th November for the next Milner Seminar. Talks will be followed by networking and refreshments. ...

    Microfluidic Embedded Electronics ManufacturingMicrofluidic Embedded Electronics Manufacturing
    9 October 2024

    More on Microfluidic Embedded Electronics Manufacturing

    IPFL recently developed a sophisticated component that integrates embedded electronics within a microfluidic system using advanced micro 3D printing technology. Leveraging BMF’s 10µm and 2µm resolution systems, IPFL produced an intricate connector that seamlessly joins two bioreactors, ...

    Nordics
    7 October 2024

    Guardtech Group gearing up for Nordics exhibition double at R3 and Tema Renrum

    THE GUARDTECH GROUP are all set for an exciting double expo appearance in the Nordics this autumn at the R3 Nordic Annual Symposium & Exhibition in October and Tema Renrum a month later.  R3 takes place at the Lily Country Club in Kløfta, Norway on 22-23 October, bringing toge...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 44
    • Page 45
    • Current page 46
    • Page 47
    • Page 48
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS